EN | UA
EN | UA

Help Support

Back

Gastroenterology

Filter By Diseases (0)

How much time do you have? in mins

All Content

166
Summaries

Tegoprazan for functional dyspepsia: A multicenter trial on effic...

Tegoprazan (50 mg), a potassium-competitive acid blocker, is effective and safe for treating functional dyspepsia, offering prominent symptom rel...

214
Medical News

Statins cut fibrosis risk in MASLD patients: New findings!

Both high and moderate-intensity statins show a protective effect against fibrosis deterioration in MASLD.

222
Medical News

Tongxieyaofang eases IBS through CHRM3 regulation and gut barrier...

The decoction of Tongxieyaofang alleviates irritable bowel syndrome symptoms by influencing CHRM3 and gut barrier function.

158
Summaries

Evaluation of antimicrobial concentrations in gastric tissues for...

Optimizing the levels and distribution of antibacterial drugs in the gastric mucosa is crucial for achieving effective H. pylori elimination rate...

225
Medical News

Study reveals new findings for erosive esophagitis therapy

Potassium-competitive acid blockers are safe and effective, especially for 2-week short-term use, severe erosive esophagitis, and maintenance the...

175
Medical News

Fexuprazan offers superior gastritis relief in two weeks compared...

Fexuprazan outperforms Rebamipide in treating acute gastritis over two weeks and matches its effectiveness over four weeks, thereby offering quic...

140
Summaries

Long-term mortality in alcohol-related liver disease: Insights fr...

Patients with alcohol-related liver disease face a high risk of death due to liver disease long after diagnosis, with specific cancers like hepat...

313
Medical News

Study: Tirzepatide for fight against steatohepatitis and liver fi...

Tirzepatide notably improves liver condition and fibrosis outcomes, and warrants consideration for inclusion in treatment strategies.

198
Summaries

Do lifestyle changes lower the risk of mortality in NAFLD patient...

Adopting a healthy lifestyle drastically lowers all-cause and cardiovascular mortality risks in patients with nonalcoholic fatty liver disease, w...

226
Medical News

Dialysis fatigue and recovery time remain unaffected by PPIs

Proton pump inhibitors do not affect recovery time or fatigue in hemodialysis patients, confirming their safety in managing these symptoms.

183
Summaries

Xiangsha Liujunzi effective and safe for functional dyspepsia

Gastrointestinal health can be improved with Xiangsha Liujunzi decoction which enhances motility, protects the mucosa, and moderates inflammation...

204
Medical News

Serum Angpt-2: Key diagnostic biomarker for diabetic kidney disea...

Serum Angiopoietin-2 shows immense potential as an early marker for diabetic kidney disease in children, supporting its future therapeutic prospe...

Try: